To include your compound in the COVID-19 Resource Center, submit it here.

Celgene beats Street by a penny

CELG posted third quarter EPS of $0.05, a penny above the Street's $0.04 consensus

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE